Cargando…
Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistance
Standard fractionated radiotherapy for the treatment of cancer consists of daily irradiation of 2-Gy X-rays, 5 days a week for 5–8 weeks. To understand the characteristics of radioresistant cancer cells and to develop more effective radiotherapy, we established a series of novel, clinically relevant...
Autores principales: | Fukumoto, Motoi, Amanuma, Tatsuya, Kuwahara, Yoshikazu, Shimura, Tsutomu, Suzuki, Masatoshi, Mori, Shiro, Kumamoto, Hiroyuki, Saito, Yohei, Ohkubo, Yasuhito, Duan, Zhenfeng, Sano, Kenji, Oguchi, Tomohiro, Kainuma, Kazuyuki, Usami, Shinichi, Kinoshita, Kengo, Lee, Inchul, Fukumoto, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462352/ https://www.ncbi.nlm.nih.gov/pubmed/25098609 http://dx.doi.org/10.1111/cas.12489 |
Ejemplares similares
-
Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors
por: Kuwahara, Yoshikazu, et al.
Publicado: (2014) -
Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells
por: Shimura, T, et al.
Publicado: (2012) -
Distribution of Artificial Radionuclides in Abandoned Cattle in the Evacuation Zone of the Fukushima Daiichi Nuclear Power Plant
por: Fukuda, Tomokazu, et al.
Publicado: (2013) -
The Effects of Hydrogen Peroxide and/or Radiation on the Survival of Clinically Relevant Radioresistant Cells
por: Kuwahara, Yoshikazu, et al.
Publicado: (2020) -
The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation
por: Matsuoka, Yuichiro, et al.
Publicado: (2022)